[1] Döhner H, Weisdorf DJ, Bloomfield CD. Acute Myeloid Leukemia. The New England journal of medicine. 2015;373:1136-52.
[2] Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424-47.
[3] Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson AG, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. The New England journal of medicine. 2013;368:2059-74.
[4] Huarte M. The emerging role of lncRNAs in cancer. Nature medicine. 2015;21:1253-61.
[5] Giulietti M, Righetti A, Principato G, Piva F. LncRNA co-expression network analysis reveals novel biomarkers for pancreatic cancer. Carcinogenesis. 2018;39:1016-25.
[6] Liu M, Gou L, Xia J, Wan Q, Jiang Y, Sun S, et al. LncRNA ITGB2-AS1 Could Promote the Migration and Invasion of Breast Cancer Cells through Up-Regulating ITGB2. Int J Mol Sci. 2018;19.
[7] Dai J, Xu LJ, Han GD, Jiang HT, Sun HL, Zhu GT, et al. Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/beta-catenin signalling and predicts favourable prognosis. Artif Cells Nanomed Biotechnol. 2018;46:S783-S90.
[8] Li N, Zhan X. Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer. The EPMA journal. 2019;10:273-90.
[9] Yang M, Qin Q, Zhu J, Guo Y, Yin T, Wu H, et al. Long noncoding RNA ITGB2-AS1 promotes growth and metastasis through miR-4319/RAF1 axis in pancreatic ductal adenocarcinoma. J Cell Physiol. 2020.
[10] Ghafouri-Fard S, Taherian-Esfahani Z, Dashti S, Kholghi Oskooei V, Taheri M, Samsami M. Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer. Epma j. 2020;114:104415.
[11] Bednarczyk M, Stege H, Grabbe S, Bros M. β2 Integrins-Multi-Functional Leukocyte Receptors in Health and Disease. International journal of molecular sciences. 2020;21.
[12] Oellerich T, Oellerich MF, Engelke M, Münch S, Mohr S, Nimz M, et al. β2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis. Blood. 2013;121.
[13] Zhou J-D, Zhang T-J, Li X-X, Ma J-C, Guo H, Wen X-M, et al. Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies. Journal of cellular and molecular medicine. 2017;21:1468-81.
[14] Zhou J-D, Wang Y-X, Zhang T-J, Li X-X, Gu Y, Zhang W, et al. Identification and validation of SRY-box containing gene family member methylation as a prognostic and predictive biomarker in myeloid malignancies. Clinical epigenetics. 2018;10:92.
[15] Zhang T-J, Zhou J-D, Zhang W, Lin J, Ma J-C, Wen X-M, et al. overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia. Clinical epigenetics. 2018;10:47.
[16] Xu Z-J, Ma J-C, Zhou J-D, Wen X-M, Yao D-M, Zhang W, et al. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia. Journal of translational medicine. 2019;17:102.
[17] Sun G-K, Tang L-J, Zhou J-D, Xu Z-J, Yang L, Yuan Q, et al. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia. Cancer medicine. 2019;8:6393-402.
[18] Liu Y, Cheng Z, Pang Y, Cui L, Qian T, Quan L, et al. Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia. 2019;12:51.
[19] Yang L, Zhou J-D, Zhang T-J, Ma J-C, Xiao G-F, Chen Q, et al. Overexpression of lncRNA predicts adverse prognosis in acute myeloid leukemia. Cancer management and research. 2018;10:4999-5007.
[20] Liu Y, Cheng Z, Pang Y, Cui L, Qian T, Quan L, et al. Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia. Journal of hematology & oncology. 2019;12:51.
[21] Wang C-H, Li Q-Y, Nie L, Ma J, Yao C-J, Chen F-P. LncRNA ANRIL promotes cell proliferation, migration and invasion during acute myeloid leukemia pathogenesis via negatively regulating miR-34a. The international journal of biochemistry & cell biology. 2020;119:105666.
[22] Wang X, Yang J, Guo G, Feng R, Chen K, Liao Y, et al. Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway. Molecular cancer. 2019;18:84.
[23] Zhao C, Wang S, Zhao Y, Du F, Wang W, Lv P, et al. Long noncoding RNA NEAT1 modulates cell proliferation and apoptosis by regulating miR-23a-3p/SMC1A in acute myeloid leukemia. Journal of cellular physiology. 2019;234:6161-72.
[24] Zeng C, Yu X, Lai J, Yang L, Chen S, Li Y. Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia. J Hematol Oncol. 2015;8:126.
[25] Hughes JM, Legnini I, Salvatori B, Masciarelli S, Marchioni M, Fazi F, et al. C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia. Oncotarget. 2015;6:18534-44.
[26] Wang Y, Zhou Q, Ma JJ. High expression of lnc-CRNDE presents as a biomarker for acute myeloid leukemia and promotes the malignant progression in acute myeloid leukemia cell line U937. Eur Rev Med Pharmacol Sci. 2018;22:763-70.
[27] Zhang X, Weissman SM, Newburger PE. Long intergenic non-coding RNA HOTAIRM1 regulates cell cycle progression during myeloid maturation in NB4 human promyelocytic leukemia cells. RNA Biol. 2014;11:777-87.
[28] Johansen S, Brenner AK, Bartaula-Brevik S, Reikvam H, Bruserud Ø. The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia. Int J Mol Sci. 2018;19.
[29] Sison EAR, Kurre P, Kim YM. Understanding the bone marrow microenvironment in hematologic malignancies: A focus on chemokine, integrin, and extracellular vesicle signaling. Pediatr Hematol Oncol. 2017;34:365-78.
[30] Lian XY, Zhang W, Wu DH, Ma JC, Zhou JD, Zhang ZH, et al. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia. 2018;233:9584-93.
[31] Lian XY, Ma JC, Zhou JD, Zhang TJ, Wu DH, Deng ZQ, et al. Hypermethylation of ITGBL1 is associated with poor prognosis in acute myeloid leukemia. 2019;234:9438-46.